Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Commentary

Adipose Tissue Plasticity in Catch-Up–Growth Trajectories to Metabolic Syndrome

Hyperplastic Versus Hypertrophic Catch-Up Fat

  1. Abdul G. Dulloo
  1. From the Institute of Physiology, University of Fribourg, Fribourg, Switzerland.
  1. Corresponding author: Abdul G. Dulloo, abdul.dulloo{at}unifr.ch.
Diabetes 2009 May; 58(5): 1037-1039. https://doi.org/10.2337/db09-0290
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Hyperplastic Versus Hypertrophic Catch-Up Fat

In the mid-1980s, at a time when the concept of syndrome X was being introduced by Reaven (1) to draw attention to the cardiovascular risks associated with insulin resistance and compensatory hyperinsulinemia, Tanner (2) was emphasizing a fundamental property of human growth as a target-seeking function: Children, no less than rockets, have their trajectories, governed by control systems of their genetic constitution and powered by the energy absorbed from the environment. Deflect the child from its natural growth trajectory (by acute malnutrition or a sudden lack of a hormone), and a restoring force develops, so that as soon as the missing food or the absent hormone is supplied again, the child hastens to catch-up toward its original growth curve. When it gets there, the child slows again, to adjust its path onto the old trajectory once more. How the child does this we do not know. What was also unknown (and unforeseen) then was that the “restoring force” that drives catch-up growth—long viewed as an essential feature of recovery from the deleterious effects of poor growth on development and health—could emerge as a major risk factor for disease entities of syndrome X, now more commonly known as the insulin resistance syndrome or metabolic syndrome.

There is now compelling evidence, from both epidemiological and clinical studies, that suggests that people who had low birth weight (often a marker for fetal growth constraints) or who showed reduced growth rate during infancy and childhood, but who subsequently showed catch-up growth, have higher susceptibility to abdominal obesity, glucose intolerance, type 2 diabetes, or cardiovascular diseases later in life (3–7). The risks for later obesity and type 2 diabetes seem particularly high when catch-up growth occurs early in postnatal life (4,6,7)—a pattern of accelerated growth that is common in individuals born small for gestational age. Independently of the timing of catch-up growth, however, the dynamic process of catch-up growth is characterized by a disproportionately faster rate of fat deposition relative to that of lean tissue, with this phenomenon of preferential catch-up fat intimately associated with hyperinsulinemia (8,9). The development of insulin resistance interlinked with catch-up fat could thus be an early feature of the mechanisms by which catch-up growth confers increased risk for metabolic syndrome later in life. Of central importance to our understanding of the pathophysiology of catch-up growth, therefore, is the issue of whether (and how) processes that regulate fat storage during catch-up fat may lead to a state of insulin resistance and impaired glucose tolerance.

From a standpoint of systems physiology, three fundamental autoregulatory control systems could be implicated in preferential catch-up fat: compensatory hyperphagia, an increase in fat mass at the expense of lean body mass, and an increase in metabolic efficiency, i.e., energy conservation mechanisms operating through suppressed thermogenesis and embodied in the concept of a thrifty energy metabolism. The fact that the phenomenon of preferential catch-up fat persists in the absence of hyperphagia or altered lean body mass (9,10) underscores a central role for suppressed thermogenesis as a fundamental physiological reaction to growth retardation and consequential body fat depletion or delayed adipose tissue development. It has been proposed (8,9) that because skeletal muscle is a major site for both thermogenesis and insulin-mediated glucose disposal, a reduction in muscle metabolic rate will result in diminished glucose utilization and glucose sparing, thereby leading to compensatory hyperinsulinemia. As depicted schematically in Fig. 1, this in turn would serve to redirect the spared glucose toward de novo lipogenesis and fat storage in adipose tissue. Various features of this muscle-adipose glucose redistribution hypothesis are supported by studies conducted in a rat model of postweaning semistarvation and refeeding in which an enhanced metabolic efficiency for catch-up fat during catch-up growth was exhibited (10–13). Whether such a thrifty catch-up–fat phenotype can be programmed or imprinted in response to catch-up growth, and, hence, long lasting so as to continue operating beyond the phase of catch-up growth, is not known. However, studies in men born small for gestational age are consistent with key components of the model presented in Fig. 1, namely, the existence of a state of suppressed thermogenesis as judged from their lower preprandial and postprandial resting energy expenditure, even after adjustments for weight, height, lean tissue mass, or organ size (14), and diminished muscle PI 3-kinase signaling (15)—a pathway that cross-links insulin signaling and thermogenesis in skeletal muscle (16).

FIG. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
FIG. 1.

Conceptual model depicting mechanisms by which the thrifty catch-up–fat phenotype, driven by suppressed thermogenesis, may cross-link with the development of insulin resistance and glucose intolerance. The depletion (or delayed growth/development) of the adipose tissue fat stores suppresses skeletal muscle thermogenesis, which during refeeding leads to concomitant glucose sparing and muscle insulin resistance. The resulting compensatory hyperinsulinemia serves to redirect the glucose spared from oxidation in skeletal muscle toward de novo lipogenesis and fat storage in white adipose tissue. In hyperplastic catch-up fat, a greater number of smaller adipocytes, coupled with lipogenesis, provide an efficient buffering capacity against the spared glucose and, hence, help to achieve normal glucose tolerance. By contrast, in hypertrophic catch-up fat, the low capacity for adipogenesis, coupled with lipogenesis, generates enlarged adipocytes, which are more prone to release proinflammatory cytokines and/or to spillover of lipids to nonadipocytes (with consequential ectopic lipotoxicity). This further exacerbates insulin resistance in skeletal muscle and other insulin-sensitive tissues, thereby resulting in more pronounced systemic insulin resistance and impaired glucose tolerance. The outcome of catch-up growth toward a hyperplastic or a hypertrophic catch-up–fat phenotype is determined by interactions among genetics, epigenetics, and environment.

In this issue of Diabetes, Isganaitis et al. (17) point to additional mechanisms, centered on perturbations in white adipose tissue plasticity, that could modulate the impact of a programmed thrifty catch-up–fat phenotype on glucose homeostasis. The studies were conducted in mice that, as they previously showed, exhibit rapid postnatal catch-up growth (after malnutrition-induced low birth weight) and that subsequently develop progressive glucose intolerance and obesity in the absence of hyperphagia and impaired lean tissue growth (18) (i.e., a murine model of postnatal catch-up growth whose obesity later in life seems to reside in a “programmed” suppression of thermogenesis). By applying state-of-the-art techniques of gene profiling and histology to white adipose tissue harvested during postnatal catch-up–fat deposition, Isganaitis et al. (17) found that key genes controlling the flux of glucose toward lipogenesis were upregulated, whereas the expression of genes implicated in adipocyte differentiation/proliferation was unaltered; these data are consistent with unaltered adipocyte number and marked adipocyte hypertrophy at the end of catch-up growth. These findings, together with their other observations that adipocyte number still failed to increase several weeks after the completion of catch-up growth, support the argument for the programming of a thrifty hypertrophic catch-up–fat phenotype that incorporates defective adipogenic mechanisms. However, in light of apparently contradictory results indicating that postnatal catch-up growth after fetal malnutrition programs proliferation of preadipocytes in rats (19), it remains to be demonstrated whether the defect in enhancing adipogenesis observed during catch-up–fat deposition and beyond in the mice studied by Isganaitis et al. (17) is specifically a programmed response to early postnatal catch-up growth or the consequence of an inherent, genetically determined low capacity of this mouse strain to mount an enhanced adipogenic response to excess fat accumulation. In other words, genetic-epigenetic interactions could be critical in defining hyperplastic catch-up fat versus hypertrophic catch-up fat. As depicted in Fig. 1, a hypertrophic catch-up–fat phenotype is more likely to predispose to diminished adipose tissue insulin sensitivity, enhanced secretion of proinflammatory adipokines that induce insulin resistance in all insulin-sensitive tissues, and spilling over of lipids to nonadipose tissues with consequential risks for ectopic lipotoxicity (20)—all of which would confer enhanced susceptibility for later development of various components of the metabolic syndrome.

ACKNOWLEDGMENTS

This work was supported by Swiss National Science Research Foundation Grant 3200B0-113634.

No potential conflicts of interest relevant to this article were reported.

I am grateful to Dr. Giovanni Solinas for useful comments.

Footnotes

  • See accompanying original article, p. 1192.

  • Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

  • © 2009 by the American Diabetes Association.

REFERENCES

  1. ↵
    1. Reaven GM
    : Why Syndrome X? From Harold Himsworth to the insulin resistance syndrome. Cell Metab 2005; 1: 9– 14
    OpenUrlCrossRefPubMedWeb of Science
  2. ↵
    1. Falkner F,
    2. Tanner JM
    1. Tanner JM
    : Growth as a target-seeking function: catch-up and catch-down growth in man. In Human Growth: A Comprehensive Treatise. Vol. 1, 2nd ed. Falkner F, Tanner JM Eds. London, Plenum Press, 1986, p. 167– 178
    OpenUrl
  3. ↵
    1. Eriksson JG,
    2. Forsén T,
    3. Tuomilehto J,
    4. Winter PD,
    5. Osmond C,
    6. Barker DJ
    : Catch-up growth in childhood and death from coronary heart disease: longitudinal study. BMJ 1999; 318: 427– 431
    OpenUrlAbstract/FREE Full Text
  4. ↵
    1. Ong KK,
    2. Ahmed ML,
    3. Emmett PM,
    4. Preece MA,
    5. Dunger DB
    : Association between postnatal catch-up growth and obesity in childhood: prospective cohort study. BMJ 2000; 320: 967– 971
    OpenUrlAbstract/FREE Full Text
  5. ↵
    1. Eriksson JG,
    2. Osmond C,
    3. Kajantie E,
    4. Forsén TJ,
    5. Barker DJ
    : Patterns of growth among children who later develop type 2 diabetes or its risk factors. Diabetologia 2006; 49: 2853– 2858
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    1. Ibáñez L,
    2. Ong K,
    3. Dunger DB,
    4. de Zegher F
    : Early development of adiposity and insulin resistance after catch-up weight gain in small-for-gestational-age children. J Clin Endocrinol Metab 2006; 91: 2153– 2158
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    1. Meas T,
    2. Deghmoun S,
    3. Armoogum P,
    4. Alberti C,
    5. Levy-Marchal C
    : Consequences of being born small for gestational age on body composition: an 8-year follow-up study. J Clin Endocrinol Metab 2008; 93: 3804– 3809
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Dulloo AG,
    2. Jacquet J,
    3. Montani JP
    : Pathways from weight fluctuations to metabolic diseases: focus on maladaptive thermogenesis during catch-up fat. Int J Obes Relat Metab Disord 2002; 26( Suppl. 2): S46– S57
    OpenUrlCrossRefWeb of Science
  9. ↵
    1. Dulloo AG
    : Thrifty energy metabolism in catch-up growth trajectories to insulin and leptin resistance. Best Pract Res Clin Endocrinol Metab 2008; 22: 155– 171
    OpenUrlCrossRefPubMed
  10. ↵
    1. Crescenzo R,
    2. Samec S,
    3. Antic V,
    4. Rohner-Jeanrenaud F,
    5. Seydoux J,
    6. Montani JP,
    7. Dulloo AG
    : A role for suppressed thermogenesis favoring catch-up fat in the pathophysiology of catch-up growth. Diabetes 2003; 52: 1090– 1097
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Cettour-Rose P,
    2. Samec S,
    3. Russell AP,
    4. Summermatter S,
    5. Mainieri D,
    6. Carrillo-Theander C,
    7. Montani JP,
    8. Seydoux J,
    9. Rohner-Jeanrenaud F,
    10. Dulloo AG
    : Redistribution of glucose from skeletal muscle to adipose tissue during catch-up fat: a link between catch-up growth and later metabolic syndrome. Diabetes 2005; 54: 751– 756
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Crescenzo R,
    2. Lionetti L,
    3. Mollica MP,
    4. Ferraro M,
    5. D'Andrea E,
    6. Mainieri D,
    7. Dulloo AG,
    8. Liverini G,
    9. Iossa S
    : Altered skeletal muscle subsarcolemmal mitochondrial compartment during catch-up fat after caloric restriction. Diabetes 2006; 55: 2286– 2293
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. Summermatter S,
    2. Mainieri D,
    3. Russell AP,
    4. Seydoux J,
    5. Montani JP,
    6. Buchala A,
    7. Solinas G,
    8. Dulloo AG
    : Thrifty metabolism that favors fat storage after caloric restriction: a role for skeletal muscle phosphatidylinositol-3-kinase activity and AMP-activated protein kinase. FASEB J 2008; 22: 774– 785
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Kensara OA,
    2. Wooton SA,
    3. Phillips DI,
    4. Patel M,
    5. Hoffman DJ,
    6. Jackson AA,
    7. Elia M
    : Substrate-energy metabolism and metabolic risk factors for cardiovascular disease in relation to fetal growth and adult body composition. Am J Physiol Endocrinol Metab 2006; 291: E365– E371
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Jensen CB,
    2. Martin-Gronert MS,
    3. Storgaard H,
    4. Madsbad S,
    5. Vaag A,
    6. Ozanne SE
    : Altered PI3-kinase/Akt signalling in skeletal muscle of young men with low birth weight. PLoS ONE 2008; 3: e3738
    OpenUrlCrossRefPubMed
  16. ↵
    1. Solinas G,
    2. Summermatter S,
    3. Mainieri D,
    4. Gubler M,
    5. Pirola L,
    6. Wymann MP,
    7. Rusconi S,
    8. Montani JP,
    9. Seydoux J,
    10. Dulloo AG
    : The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation. FEBS Lett 2004; 577: 539– 544
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Isganaitis E,
    2. Jimenez-Chillaron J,
    3. Woo M,
    4. Chow A,
    5. DeCoste J,
    6. Vokes M,
    7. Liu M,
    8. Kasif S,
    9. Zavacki A-M,
    10. Leshan RL,
    11. Myers MG,
    12. Patti M-E
    : Accelerated postnatal growth increases lipogenic gene expression and adipocyte size in low–birth weight mice. Diabetes 2009; 58: 1192– 1200
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Jimenez-Chillaron JC,
    2. Hernandez-Valencia M,
    3. Lightner A,
    4. Faucette RR,
    5. Reamer C,
    6. Przybyla R,
    7. Ruest S,
    8. Barry K,
    9. Otis JP,
    10. Patti ME
    : Reductions in caloric intake and early postnatal growth prevent glucose intolerance and obesity associated with low birthweight. Diabetologia 2006; 49: 1974– 1984
    OpenUrlCrossRefPubMed
  19. ↵
    1. Bol VV,
    2. Reusens BM,
    3. Remacle CA
    : Postnatal catch-up growth after fetal protein restriction programs proliferation of rat preadipocytes. Obesity (Silver Spring) 2008; 16: 2760– 2763.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Slawik M,
    2. Vidal-Puig AJ
    : Adipose tissue expandability and the metabolic syndrome. Genes Nutr 2007; 2: 41– 45
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top

In this Issue

May 2009, 58(5)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adipose Tissue Plasticity in Catch-Up–Growth Trajectories to Metabolic Syndrome
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Adipose Tissue Plasticity in Catch-Up–Growth Trajectories to Metabolic Syndrome
Abdul G. Dulloo
Diabetes May 2009, 58 (5) 1037-1039; DOI: 10.2337/db09-0290

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Adipose Tissue Plasticity in Catch-Up–Growth Trajectories to Metabolic Syndrome
Abdul G. Dulloo
Diabetes May 2009, 58 (5) 1037-1039; DOI: 10.2337/db09-0290
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Commentary

  • Lifting the Veil on the “Phosphate Flush,” a Cryptic Phenomenon of Experimental Pancreatic Islet Physiology
  • Window of Opportunity: Targeting ANGPTL4 Improves Triglyceride Levels in Maternal Obesity During Pregnancy
  • New Antidiabetes Agent Targeting Both Mitochondrial Uncoupling and Pyruvate Catabolism: Two Birds With One Stone
Show more Commentary

Commentaries

  • Adipose Tissue Malfunction Drives Metabolic Dysfunction in Alström Syndrome
  • Staying Connected: Transcriptomics in the Search for Novel Diabetic Kidney Disease Treatments
  • Going in Early: Hypoxia as a Target for Kidney Disease Prevention in Diabetes?
Show more Commentaries

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.